These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30321645)

  • 21. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
    Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Single-Center Analysis of How HLA Mismatch and Donor-Specific Antibodies Affect Short-Term Outcome After Lung Transplantation: A Pilot Study Before a Country-Wide Histocompatibility Study in Japan.
    Hirama T; Akiba M; Watanabe T; Watanabe Y; Oishi H; Okada Y
    Transplant Proc; 2024 Mar; 56(2):363-368. PubMed ID: 38320866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching.
    Kosmoliaptsis V; Mallon DH; Chen Y; Bolton EM; Bradley JA; Taylor CJ
    Am J Transplant; 2016 Jul; 16(7):2139-47. PubMed ID: 26755448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.
    Sharma A; Taverniti A; Graf N; Teixeira-Pinto A; Lewis JR; Lim WH; Alexander SI; Durkan A; Craig JC; Wong G
    Pediatr Nephrol; 2020 Jun; 35(6):1061-1068. PubMed ID: 32065279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
    Wiebe C; Rush DN; Nevins TE; Birk PE; Blydt-Hansen T; Gibson IW; Goldberg A; Ho J; Karpinski M; Pochinco D; Sharma A; Storsley L; Matas AJ; Nickerson PW
    J Am Soc Nephrol; 2017 Nov; 28(11):3353-3362. PubMed ID: 28729289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
    Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
    Front Immunol; 2022; 13():844438. PubMed ID: 35799779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation.
    Kleid L; Walter J; Moehnle P; Wichmann C; Kovács J; Humpe A; Schneider C; Michel S; Kneidinger N; Irlbeck M; Fertmann J; Dick A; Kauke T
    Transpl Int; 2024; 37():13010. PubMed ID: 39381015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
    Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
    J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eplet matching in pediatric heart transplantation: The SickKids experience.
    Cardoso B; Wang J; Kiernan J; Dipchand AI
    J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
    Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
    J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
    San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
    Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.
    Cross AR; Lion J; Loiseau P; Charron D; Taupin JL; Glotz D; Mooney N
    Hum Immunol; 2016 Nov; 77(11):1092-1100. PubMed ID: 27060781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terasaki Epitope Mismatch Burden Predicts the Development of De Novo DQ Donor-Specific Antibodies and are Associated With Adverse Allograft Outcomes.
    Willicombe M; Blow M; Santos-Nunez E; Freeman C; Brookes P; Taube D
    Transplantation; 2018 Jan; 102(1):127-134. PubMed ID: 28731902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.
    Willicombe M; Brookes P; Sergeant R; Santos-Nunez E; Steggar C; Galliford J; McLean A; Cook TH; Cairns T; Roufosse C; Taube D
    Transplantation; 2012 Jul; 94(2):172-7. PubMed ID: 22735711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eplet incompatibility in pediatric renal transplantation.
    Rãchişan AL; Dubois V; Ranchin B; Sellier-Leclerc AL; Bertholet Thomas A; Cochat P; Bacchetta J
    Pediatr Transplant; 2020 Sep; 24(6):e13721. PubMed ID: 32388894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatch epitope load predicts de novo-DSA-free survival in pediatric liver transplantation.
    Shin S; Lee M; Dente E; Yazigi N; Khan KM; Kaufman SS; Ahn J; Timofeeva OA; Ekong UD
    Pediatr Transplant; 2022 Jun; 26(4):e14251. PubMed ID: 35279919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.
    Bezstarosti S; Meziyerh S; Reinders MEJ; Voogt-Bakker K; Groeneweg KE; Roelen DL; Kers J; de Fijter JW; Heidt S
    HLA; 2023 Jul; 102(1):3-12. PubMed ID: 36841928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated human leukocyte antigen mismatches in lung re-transplantation.
    Sommer W; Hallensleben M; Ius F; Kühn C; Tudorache I; Avsar M; Salman J; Siemeni T; Greer M; Gottlieb J; Boethig D; Blasczyk R; Haverich A; Warnecke G
    Transpl Immunol; 2017 Feb; 40():1-7. PubMed ID: 27923603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.